B3GNT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.74799999317099E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.26549999999826E-05 |
Normal-vs-Stage2 |
8.248200E-04 |
Normal-vs-Stage3 |
4.154199999995E-06 |
Normal-vs-Stage4 |
2.9535263124103E-12 |
Stage1-vs-Stage2 |
2.380600E-01 |
Stage1-vs-Stage3 |
8.010000E-02 |
Stage1-vs-Stage4 |
4.74880000000955E-06 |
Stage2-vs-Stage3 |
9.071600E-01 |
Stage2-vs-Stage4 |
2.006000E-01 |
Stage3-vs-Stage4 |
1.407820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.81399999968457E-08 |
Normal-vs-AfricanAmerican |
4.20279999691076E-09 |
Normal-vs-Asian |
6.235700E-02 |
Caucasian-vs-AfricanAmerican |
3.417500E-02 |
Caucasian-vs-Asian |
6.464400E-01 |
AfricanAmerican-vs-Asian |
2.470800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.00899999466719E-09 |
Normal-vs-Female |
2.35479999999288E-05 |
Male-vs-Female |
4.522200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.88721999999641E-05 |
Normal-vs-Age(41-60Yrs) |
7.43159999982979E-07 |
Normal-vs-Age(61-80Yrs) |
3.37140000361558E-08 |
Normal-vs-Age(81-100Yrs) |
4.370900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.879800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.265000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.615000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.039200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.972000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.780200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.302200E-02 |
Normal-vs-Grade 2 |
7.219200E-03 |
Normal-vs-Grade 3 |
1.85418347342647E-12 |
Normal-vs-Grade 4 |
1.64623870091418E-12 |
Grade 1-vs-Grade 2 |
8.738600E-01 |
Grade 1-vs-Grade 3 |
7.509900E-02 |
Grade 1-vs-Grade 4 |
6.440200E-03 |
Grade 2-vs-Grade 3 |
5.78219999999297E-05 |
Grade 2-vs-Grade 4 |
5.72410000510004E-08 |
Grade 3-vs-Grade 4 |
8.597100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.251910E-02 |
Normal-vs-ccB subtype |
6.83390000144612E-09 |
ccA subtype-vs-ccB subtype |
8.20920000000891E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.52039999995668E-06 |
Normal-vs-N1 |
4.36779999946069E-08 |
N0-vs-N1 |
5.102400E-03 |
|
|